Cholera Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
The global cholera vaccines market size reached US$ 4.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.2 Million by 2028, exhibiting a growth rate (CAGR) of 11.1% during 2023-2028.
Cholera is an intestinal disease caused by bacterial infections that spread through contaminated food and water. It leads to severe diarrhea, dehydration, abdominal pain, fever, rapid heart rate, loss of skin elasticity, low blood pressure, muscle cramps, and dry mucous membranes, such as the inside of the mouth, throat, nose, and eyelids. It is presently a global threat to public health, which can be prevented through the vaccine. The cholera vaccine exposes a small dose of live cholera bacteria in the body that helps develop immunity against the disease. It can be given orally or injected intradermally or intramuscularly in the body.
Cholera Vaccines Market Trends:
The growing prevalence of cholera on account of poor hygiene and sanitation represents one of the major factors driving the market. In addition, there is a rise in the use of contaminated water for agriculture and olericulture across the globe. This, along with the increasing consumption of street and fast food due to the hectic lifestyles of individuals, is propelling the growth of the market. Moreover, there is a considerable rise in water pollution on account of sewage and factory wastes getting discharged into lakes and rivers. As a result, people are consuming contaminated seafood worldwide, which, in turn, is resulting in the spread of cholera. Additionally, rising awareness about cholera through initiatives of non-governmental organizations (NGOs), along with numerous immunization programs introduced by governments of several countries to reduce vaccine-preventable diseases, is positively influencing the market. Furthermore, key market players are extensively investing in research and development (R&D) activities to provide more efficient and cost-effective cholera vaccines, which is projected to propel the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cholera vaccines market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on vaccine type, product and end user.
Breakup by Vaccine Type:
Whole Cell V. Cholerae O1 with Recombinant B-Subunit
Killed Oral O1 and O139
Breakup by Product:
Dukoral
Shanchol
Vaxchora
Euvichol and Euvichol-Plus
Others
Breakup by End User:
Hospitals and Clinics
Research and Academic Laboratories
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Astellas Pharma Inc., Celldex Therapeutics Inc. (Avant Immunotherapeutics Inc.), Emergent BioSolutions Inc., Eubiologics Co. Ltd., Johnson & Johnson, Merck & Co. Inc, Pfizer Inc., PharmaChoice Canada Inc, Sanofi S.A., Takeda Pharmaceutical Company Limited and Valneva SE.
Key Questions Answered in This Report:
How has the global cholera vaccines market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global cholera vaccines market?
What are the key regional markets?
What is the breakup of the market based on the vaccine type?
What is the breakup of the market based on the product?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global cholera vaccines market and who are the key players?
What is the degree of competition in the industry?
Cholera is an intestinal disease caused by bacterial infections that spread through contaminated food and water. It leads to severe diarrhea, dehydration, abdominal pain, fever, rapid heart rate, loss of skin elasticity, low blood pressure, muscle cramps, and dry mucous membranes, such as the inside of the mouth, throat, nose, and eyelids. It is presently a global threat to public health, which can be prevented through the vaccine. The cholera vaccine exposes a small dose of live cholera bacteria in the body that helps develop immunity against the disease. It can be given orally or injected intradermally or intramuscularly in the body.
Cholera Vaccines Market Trends:
The growing prevalence of cholera on account of poor hygiene and sanitation represents one of the major factors driving the market. In addition, there is a rise in the use of contaminated water for agriculture and olericulture across the globe. This, along with the increasing consumption of street and fast food due to the hectic lifestyles of individuals, is propelling the growth of the market. Moreover, there is a considerable rise in water pollution on account of sewage and factory wastes getting discharged into lakes and rivers. As a result, people are consuming contaminated seafood worldwide, which, in turn, is resulting in the spread of cholera. Additionally, rising awareness about cholera through initiatives of non-governmental organizations (NGOs), along with numerous immunization programs introduced by governments of several countries to reduce vaccine-preventable diseases, is positively influencing the market. Furthermore, key market players are extensively investing in research and development (R&D) activities to provide more efficient and cost-effective cholera vaccines, which is projected to propel the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cholera vaccines market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on vaccine type, product and end user.
Breakup by Vaccine Type:
Whole Cell V. Cholerae O1 with Recombinant B-Subunit
Killed Oral O1 and O139
Breakup by Product:
Dukoral
Shanchol
Vaxchora
Euvichol and Euvichol-Plus
Others
Breakup by End User:
Hospitals and Clinics
Research and Academic Laboratories
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Astellas Pharma Inc., Celldex Therapeutics Inc. (Avant Immunotherapeutics Inc.), Emergent BioSolutions Inc., Eubiologics Co. Ltd., Johnson & Johnson, Merck & Co. Inc, Pfizer Inc., PharmaChoice Canada Inc, Sanofi S.A., Takeda Pharmaceutical Company Limited and Valneva SE.
Key Questions Answered in This Report:
How has the global cholera vaccines market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global cholera vaccines market?
What are the key regional markets?
What is the breakup of the market based on the vaccine type?
What is the breakup of the market based on the product?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global cholera vaccines market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL CHOLERA VACCINES MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY VACCINE TYPE
6.1 Whole Cell V. Cholerae O1 with Recombinant B-Subunit
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Killed Oral O1 and O139
6.2.1 Market Trends
6.2.2 Market Forecast
7 MARKET BREAKUP BY PRODUCT
7.1 Dukoral
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Shanchol
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Vaxchora
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Euvichol and Euvichol-Plus
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 MARKET BREAKUP BY END USER
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Research and Academic Laboratories
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Astellas Pharma Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Celldex Therapeutics Inc. (Avant Immunotherapeutics Inc.)
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Emergent BioSolutions Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Eubiologics Co. Ltd.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.5 Johnson & Johnson
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Merck & Co. Inc
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Pfizer Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 PharmaChoice Canada Inc
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Sanofi S.A.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Takeda Pharmaceutical Company Limited.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Valneva SE
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL CHOLERA VACCINES MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY VACCINE TYPE
6.1 Whole Cell V. Cholerae O1 with Recombinant B-Subunit
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Killed Oral O1 and O139
6.2.1 Market Trends
6.2.2 Market Forecast
7 MARKET BREAKUP BY PRODUCT
7.1 Dukoral
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Shanchol
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Vaxchora
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Euvichol and Euvichol-Plus
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 MARKET BREAKUP BY END USER
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Research and Academic Laboratories
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Astellas Pharma Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Celldex Therapeutics Inc. (Avant Immunotherapeutics Inc.)
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Emergent BioSolutions Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Eubiologics Co. Ltd.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.5 Johnson & Johnson
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Merck & Co. Inc
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Pfizer Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 PharmaChoice Canada Inc
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Sanofi S.A.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Takeda Pharmaceutical Company Limited.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Valneva SE
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
LIST OF TABLES
Table 1: Global: Cholera Vaccines Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Cholera Vaccines Market Forecast: Breakup by Vaccine Type (in Million US$), 2023-2028
Table 3: Global: Cholera Vaccines Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 4: Global: Cholera Vaccines Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 5: Global: Cholera Vaccines Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Cholera Vaccines Market: Competitive Structure
Table 7: Global: Cholera Vaccines Market: Key Players
Table 1: Global: Cholera Vaccines Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Cholera Vaccines Market Forecast: Breakup by Vaccine Type (in Million US$), 2023-2028
Table 3: Global: Cholera Vaccines Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 4: Global: Cholera Vaccines Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 5: Global: Cholera Vaccines Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Cholera Vaccines Market: Competitive Structure
Table 7: Global: Cholera Vaccines Market: Key Players
LIST OF FIGURES
Figure 1: Global: Cholera Vaccines Market: Major Drivers and Challenges
Figure 2: Global: Cholera Vaccines Market: Sales Value (in Million US$), 2017-2022
Figure 3: Global: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 4: Global: Cholera Vaccines Market: Breakup by Vaccine Type (in %), 2022
Figure 5: Global: Cholera Vaccines Market: Breakup by Product (in %), 2022
Figure 6: Global: Cholera Vaccines Market: Breakup by End User (in %), 2022
Figure 7: Global: Cholera Vaccines Market: Breakup by Region (in %), 2022
Figure 8: Global: Cholera Vaccines (Whole Cell V. Cholerae O1 with Recombinant B-Subunit) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Cholera Vaccines (Whole Cell V. Cholerae O1 with Recombinant B-Subunit) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Cholera Vaccines (Killed Oral O1 and O139) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Cholera Vaccines (Killed Oral O1 and O139) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Cholera Vaccines (Dukoral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Cholera Vaccines (Dukoral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Cholera Vaccines (Shanchol) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Cholera Vaccines (Shanchol) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Cholera Vaccines (Vaxchora) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Cholera Vaccines (Vaxchora) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Cholera Vaccines (Euvichol and Euvichol-Plus) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Cholera Vaccines (Euvichol and Euvichol-Plus) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Cholera Vaccines (Other Product) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Cholera Vaccines (Other Product) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Cholera Vaccines (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Cholera Vaccines (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Cholera Vaccines (Research and Academic Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Cholera Vaccines (Research and Academic Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Cholera Vaccines (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Cholera Vaccines (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: North America: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: North America: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: United States: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: United States: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Canada: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Canada: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Asia-Pacific: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Asia-Pacific: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: China: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: China: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Japan: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Japan: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: India: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: India: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: South Korea: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: South Korea: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Australia: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Australia: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Indonesia: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Indonesia: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Others: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Others: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Europe: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Europe: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Germany: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Germany: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: France: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: France: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: United Kingdom: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: United Kingdom: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Italy: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Italy: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Spain: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Spain: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Russia: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Russia: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Others: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Others: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Latin America: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Latin America: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Brazil: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Brazil: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Mexico: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Mexico: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Others: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Others: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Middle East and Africa: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Middle East and Africa: Cholera Vaccines Market: Breakup by Country (in %), 2022
Figure 76: Middle East and Africa: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Global: Cholera Vaccines Industry: SWOT Analysis
Figure 78: Global: Cholera Vaccines Industry: Value Chain Analysis
Figure 79: Global: Cholera Vaccines Industry: Porter's Five Forces Analysis
Figure 1: Global: Cholera Vaccines Market: Major Drivers and Challenges
Figure 2: Global: Cholera Vaccines Market: Sales Value (in Million US$), 2017-2022
Figure 3: Global: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 4: Global: Cholera Vaccines Market: Breakup by Vaccine Type (in %), 2022
Figure 5: Global: Cholera Vaccines Market: Breakup by Product (in %), 2022
Figure 6: Global: Cholera Vaccines Market: Breakup by End User (in %), 2022
Figure 7: Global: Cholera Vaccines Market: Breakup by Region (in %), 2022
Figure 8: Global: Cholera Vaccines (Whole Cell V. Cholerae O1 with Recombinant B-Subunit) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Cholera Vaccines (Whole Cell V. Cholerae O1 with Recombinant B-Subunit) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Cholera Vaccines (Killed Oral O1 and O139) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Cholera Vaccines (Killed Oral O1 and O139) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Cholera Vaccines (Dukoral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Cholera Vaccines (Dukoral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Cholera Vaccines (Shanchol) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Cholera Vaccines (Shanchol) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Cholera Vaccines (Vaxchora) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Cholera Vaccines (Vaxchora) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Cholera Vaccines (Euvichol and Euvichol-Plus) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Cholera Vaccines (Euvichol and Euvichol-Plus) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Cholera Vaccines (Other Product) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Cholera Vaccines (Other Product) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Cholera Vaccines (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Cholera Vaccines (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Cholera Vaccines (Research and Academic Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Cholera Vaccines (Research and Academic Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Cholera Vaccines (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Cholera Vaccines (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: North America: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: North America: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: United States: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: United States: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Canada: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Canada: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Asia-Pacific: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Asia-Pacific: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: China: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: China: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Japan: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Japan: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: India: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: India: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: South Korea: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: South Korea: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Australia: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Australia: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Indonesia: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Indonesia: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Others: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Others: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Europe: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Europe: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Germany: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Germany: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: France: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: France: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: United Kingdom: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: United Kingdom: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Italy: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Italy: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Spain: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Spain: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Russia: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Russia: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Others: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Others: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Latin America: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Latin America: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Brazil: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Brazil: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Mexico: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Mexico: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Others: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Others: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Middle East and Africa: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Middle East and Africa: Cholera Vaccines Market: Breakup by Country (in %), 2022
Figure 76: Middle East and Africa: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Global: Cholera Vaccines Industry: SWOT Analysis
Figure 78: Global: Cholera Vaccines Industry: Value Chain Analysis
Figure 79: Global: Cholera Vaccines Industry: Porter's Five Forces Analysis
